M&A Update – Feb 25

– INE.to to be acquired by CDPQ for $13.75 cash per share, 57.9% premium, $10.0 billion
– CHX / SLB announced agreement to sell all of ChampionX’s equity interests in US Synthetic Corporation to LongRange Capital, cleared HSR, Norwegian Phase 2 review, closing end of Q1 or early Q2 2025
– DND.to announced it received unsolicited proposal at $20.00 cash per share, not in any negotiations with any third party
– HCP / IBM cleared UK CMA
– ACCD / Transcarent cleared HSR, closing Q2 2025
– PLYA / H launched tender offer, expires Apr 25
– BERY / AMCR votes